Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line

Human Gene Therapy

Volumn 9, Issue 5, 1998, Pages 621-628

  Michienzi, Alessandro ^a   Conti, Lucia ^b   Varano, Barbara ^b   Prislei, Silvia ^a   Gessani, Sandra ^b   Bozzoni, Irene ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CHIMERIC PROTEIN; MESSENGER RNA; RIBOZYME; SMALL NUCLEAR RNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CLONE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; LYMPHOBLASTOID CELL LINE; NONHUMAN; RNA SPLICING; RNA TRANSPORT; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032549623     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.5-621     Document Type: Article

References (14)

1. ALTMAN, S. (1993). RNA enzyme-directed gene therapy. Proc. Natl. Acad. Sci. USA 90, 10898-10900
2. BERTRAND, E., CASTANOTTO, D., ZHOU, C., CARBONELLE, C., LEE, N.S., GOOD, P., CHATTERJEE, S., GRANGE, T., PICTET, R., KOHN, D., ENGELKE, D., and ROSSI, J.J. (1997). The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3, 75-88.
3. BIASOLO, M.A., RADAELLI, A., DEL PUP, L., FRANCHIN, E., DE GIULI-MORGHEN, C., and PALU', G. (1996). A New Antisense tRNA Construct for the Genetic Treatment of Human Immunodficiency Virus Type 1 infection. J. Virol. 70, 2154-2161.
4. CAGNON, L., CUCCHIARINI, M., LEVEBVRE, J.C., and DEAGLIO, A. (1995). Protection of a T-cell line from human immunodeficiency virus replication by stable expression of a short antisense RNA sequence carried by shuttle RNA molecule. J. AIDS Hum. Retrovir. 9, 349-358.
5. CHANG, D.D., and SHARP, P.A. (1989). Regulation by HIV rev depends upon recognition of splice sites. Cell 59, 789-795.
6. CHIRGWIN, J.M., MACDONALD, R.J., and RYTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5295-5299.
7. COUTURE, L., and STINCHCOMB, D. (1996). Anti-gene therapy: use of ribozymes to inhibit gene function. Trends Genetics 12, 510-515.
8. DIANZANI, F., CAPOBIANCHI, M.R., ANTONELLI, G., AMICUCCI, P., and DE MARCO, F. (1989). Susceptibility of human immunodeficiency virus to antiviral agents measures by infectious virus yield reduction. Antiviral Res. 11, 299-306.
9. DROPULIC, B., and JEANG, K.T. (1994). Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. Hum. Gene Ther. 5, 927-939
10. DROPULIC, B., ELKINS, D.A., ROSSI, J.J., and SARVER, N. (1993). Ribozymes: Use as anti-HIV therapeutic molecules. Antisense Res. Dev. 3, 87-94.
11. DUAN, L., ZHU, M., BAGASRA, O., and POMERANTZ, R.J. (1995). Intracellular immunization against HIV-1 infection of human T-lymphocytcs: Utility of anti-rev single chain variable fragments. Hum. Gene Then 6, 1561-1573.
12. GILBOA, E., and SMITH, C. (1994). Gene therapy for infectious diseases: The AIDS model. Trends Genet. 10, 139-143.
13. HASELOFF, J., and GERLACH, W.L. (1988). Simple RNA enzymes with new highly specific endoribonuclease activies. Nature 334, 585-591.
14. HERTEL, K.J., PARDI, A., UHLENBECK, O.C., KOIZUMI, M., OHTSUKA, E., UESUGI, S., CEDERGREN, R., ECKSTEIN, F., GERLACH, W.L., HODGSON, R., and SYMONS, R.H. (1992). Numbering system for the hammerhead. Nucleic Acids Res. 20, 3252.